N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]oxazin-8a(8H)-YL)-thiazol-4-YL) amides

wherein the variables R1, R2, R3, R4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Saved in:
Bibliographic Details
Main Authors Brodney, Michael Aaron, O'Neill, Brian Thomas, Butler, Christopher Ryan, Zhang, Lei
Format Patent
LanguageEnglish
Published 09.04.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:wherein the variables R1, R2, R3, R4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Bibliography:Application Number: US201715678511